XML 37 R25.htm IDEA: XBRL DOCUMENT v3.25.2
Revenues (Tables)
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The Company's revenue by product line, and related approximate percentage of total sales, for the three and six months ended June 30, 2025 and 2024 were as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
20252024*20252024*
Nylon$79,503 20%$103,217 23%$167,871 21%$187,606 24%
Caprolactam66,424 16%81,303 18%133,856 17%142,779 18%
Plant Nutrients156,770 38%147,339 32%285,011 36%242,035 30%
Chemical Intermediates107,325 26%121,620 27%201,075 26%217,888 28%
Total$410,022 100%$453,479 100%$787,813 100%$790,308 100%
* The Company transferred certain products between its Chemical Intermediates product line and its Plant Nutrients product line to align more closely with its current sales structure. Historical information has been reclassified to reflect these changes for all periods presented in the Consolidated Financial Statements. Total revenue amounts were not impacted for either period.

The Company's revenues by geographic area, and related approximate percentage of total sales, for the three and six months ended June 30, 2025 and 2024 were as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
United States$358,671 87%$401,859 89%$679,118 86%$686,447 87%
International *51,351 13%51,620 11%108,695 14%103,861 13%
Total$410,022 100%$453,479 100%$787,813 100%$790,308 100%
* Predominantly Latin America and Canada
Schedule of Deferred Income and Customer Advances Below is a roll-forward of Deferred income and customer advances for the six months ended June 30, 2025:
Opening balance January 1, 2025$37,538 
Additional cash advances— 
Less amounts recognized in revenues(35,680)
Ending balance June 30, 2025$1,858